PRESCRIPTION TREND AND DRUG ADHERENCE OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION

被引：0
|
作者：
Han, S. [1 ]
Jeong, H. S. [1 ]
Kim, H. T. [1 ]
Suh, H. S. [1 ]
机构：
[1] Pusan Natl Univ, Busan, South Korea
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV74
引用
收藏
页码：A272 / A272
页数：1
相关论文
共 50 条
  • [41] Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (11): : 1115 - 1116
  • [42] Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation
    Desteghe, Lien
    Vijgen, Johan
    Koopman, Pieter
    Dilling-Boer, Dagmara
    Schurmans, Joris
    Dendale, Paul
    Heidbuchel, Hein
    EUROPEAN HEART JOURNAL, 2018, 39 (16) : 1394 - 1403
  • [43] Oral Anticoagulation in Japanese Patients With Atrial Fibrillation - Insight to the Use of Non-Vitamin K Antagonist Oral Anticoagulants
    Gomez-Molina, Miriam
    Valdes, Mariano
    Marin, Francisco
    CIRCULATION JOURNAL, 2015, 79 (02) : 292 - 294
  • [44] Comparative Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation
    Senoo, Keitaro
    Lip, Gregory Y. H.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (02): : 146 - 153
  • [45] The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
    Grymonprez, Maxim
    Petrovic, Mirko
    De Backer, Tine L.
    Steurbaut, Stephane
    Lahousse, Lies
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (02) : 135 - 148
  • [46] Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Hu, Mu-Mei
    Wang, Jui
    Chien, Kuo-Liong
    Su, Chin-Ling
    Lin, Shin-Yi
    Wu, Fe-Lin Lin
    Lin, Zhen-Fang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (04) : 276 - 286
  • [47] Efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and hypertrophic cardiomyopathy
    刘圆圆
    China Medical Abstracts(Internal Medicine), 2022, 39 (02) : 100 - 100
  • [48] Eligibility criteria for non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in the real world
    Augusto, J. B.
    Santos, M. Borges
    Roque, D.
    Silva, M.
    Castro, J.
    Sala, J.
    Faustino, A.
    Branco, M.
    Morais, J.
    Morais, C.
    EUROPEAN HEART JOURNAL, 2016, 37 : 236 - 236
  • [49] Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
    Kim, Kyu
    Lee, Yong-Joon
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    KOREAN CIRCULATION JOURNAL, 2018, 48 (05) : 406 - 417
  • [50] Favorable effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with liver cirrhosis
    Yu, H. T.
    Kim, K.
    Kim, T. H.
    Uhm, J. S.
    Sung, J. H.
    Kim, J. Y.
    Pak, H. N.
    Lee, M. H.
    Joung, B.
    EUROPEAN HEART JOURNAL, 2017, 38 : 615 - 616
12345